Academic-industry research collaborations have long been a source of controversy in medicine. Advocates suggest that collaborations can focus academic researchers on important clinical and translational research problems and provide them with financial and capability-enhancing technical resources.1 Critics maintain that industry engagement distracts from, or distorts, the teaching and research missions of academia.2 Although regulatory and compliance frameworks have been established to govern these relationships, controversy continues to surround efforts to enhance industry and academia collaborations.
Jain SH, Rosenblatt M, Duke J. Is Big Data the New Frontier for Academic-Industry Collaboration?. JAMA. 2014;311(21):2171–2172. doi:10.1001/jama.2014.1845